Kane Biotech Presents revyve® Clinical Data at Symposium on Advanced Wound Care (SAWC) Spring Conference Apr 16, 2026
Kane Biotech Announces Publication in Frontiers in Antibiotics Highlighting Advancements in Treating Antibiotic Tolerant Biofilms Mar 17, 2026
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal Feb 20, 2026
Kane Biotech Announces FDA 510(k) Clearance for revyve® Antimicrobial Skin and Wound Cleanser Feb 17, 2026
Kane Biotech Announces Closing of Private Placement Offering with an Insider of the Company Dec 18, 2025
